ACOR
Acorda Therapeutics
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
151 hedge funds and large institutions have $157M invested in Acorda Therapeutics in 2019 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 57 increasing their positions, 42 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less first-time investments, than exits
New positions opened: | Existing positions closed:
65% less capital invested
Capital invested by funds: $451M → $157M (-$294M)
Holders
151
Holding in Top 10
–
Calls
$810K
Puts
$1.2M
Top Buyers
| 1 | +$6.28M | |
| 2 | +$2.38M | |
| 3 | +$1.7M | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$1.26M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.22M |
Top Sellers
| 1 | -$8.65M | |
| 2 | -$7.01M | |
| 3 | -$2.91M | |
| 4 |
Teacher Retirement System of Texas
Austin,
Texas
|
-$2.74M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
-$1.84M |